OXELTIS is an independent medchem oriented service company managed by former researchers from Idenix Pharmaceuticals and located in Montpellier - France.
Oxeltis is a company that delivers integrated solutions for managing and executing medicinal and fine organic chemistry projects. We run FTE programs (hit to lead optimization) with an expertise in some specialty chemistry such as macrocycles (pseudopeptides), mono & poly/oligosaccharides (sugar phosphates, iminosugars, saccharidic antigens…) nucleos(t)ides (modified nucleosides, phosphoramidites…), short peptides, linkers and PROTACs  (Ligands E3 CRBN ligase library ) applied to discovery programs in oncology, antivirals and antibiotics mainly.
OXELTIS client portfolio includes 40+ European and US companies from biotech to top 10 pharmaceutical companies.
With its team of experienced medchem chemists, OXELTIS is proactive in providing rapid, high quality and competitive work.

Specific expertise:
-	Contract research in medicinal chemistry, FTE programs for hit to lead optimization in different fields including antivirals, anticancer and antibiotics. 
-	Fee-for-service custom synthesis expertise in heterocycles (in various fields), modified sugars (sugar phosphates, iminosugars, unnatural sugars…monosaccharides and oligosaccharides...), nucleoside/nucleotide (sugar and base-modified nucleosides, phosphoramidites…), macrocycles (e.g. antiviral antiproteases) .

https://oxeltis.com/
https://twitter.com/Oxeltis_CRO

OXELTIS

Org chart

Teams

Offices